Takeda Pharmaceutical Company Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/13/2025 | 13.16 M | $174.27 M | 0.19% | 0.83% |
| MORGAN STANLEY | 02/14/2025 | 5.60 M | $74.15 M | 4.59% | 0.35% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 4.63 M | $61.28 M | 1.48% | 0.29% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 4.22 M | $55.82 M | -9.04% | 0.27% |
| FMR LLC | 02/13/2025 | 3.39 M | $44.83 M | 16.41% | 0.21% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 3.24 M | $42.91 M | 1.97% | 0.20% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 3.08 M | $40.77 M | -4.33% | 0.19% |
| BRANDES INVESTMENT PARTNERS, LP | 02/10/2025 | 3.04 M | $40.24 M | -5.94% | 0.19% |
| VAN ECK ASSOCIATES CORP | 01/29/2025 | 2.21 M | $29.27 M | 1.62% | 0.14% |
| BLACKROCK, INC. | 02/07/2025 | 2.20 M | $29.18 M | 16.56% | 0.14% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.00 M | $26.49 M | -41.26% | 0.13% |
| NORTHERN TRUST CORP | 02/14/2025 | 1.87 M | $24.81 M | 14.56% | 0.12% |
| CITADEL ADVISORS LLC | 02/14/2025 | 1.68 M | $22.24 M | -0.94% | 0.11% |
| UBS GROUP AG | 02/14/2025 | 1.66 M | $22.00 M | 2,175.74% | 0.11% |
| MANAGED ASSET PORTFOLIOS, LLC | 02/07/2025 | 1.42 M | $18.77 M | -12.37% | 0.09% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.18 M | $15.62 M | 136.00% | 0.07% |
| ENVESTNET ASSET MANAGEMENT INC | 02/13/2025 | 984,678 | $13.04 M | -31.88% | 0.06% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 863,678 | $11.44 M | -11.69% | 0.05% |
| SUMMIT GLOBAL INVESTMENTS | 02/11/2025 | 729,200 | $9.66 M | 75.47% | 0.05% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 02/13/2025 | 522,030 | $6.91 M | -59.25% | 0.03% |
| TORONTO DOMINION BANK | 02/19/2025 | 510,600 | $6.76 M | 100.00% | 0.03% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 500,677 | $6.63 M | 15,448.98% | 0.03% |
| QUANTINNO CAPITAL MANAGEMENT LP | 02/14/2025 | 481,833 | $6.38 M | 33.21% | 0.03% |
| NATIXIS ADVISORS, L.P. | 02/10/2025 | 478,579 | $6.34 M | 4.71% | 0.03% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 446,764 | $5.92 M | 100.00% | 0.03% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 435,141 | $5.76 M | -1.25% | 0.03% |
| FEDERATED HERMES, INC. | 02/13/2025 | 435,034 | $5.76 M | -19.85% | 0.03% |
| ROYAL BANK OF CANADA | 02/14/2025 | 397,348 | $5.26 M | -14.38% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 362,517 | $4.80 M | -59.55% | 0.02% |
| CLEAN YIELD GROUP | 01/13/2025 | 360,091 | $4.77 M | -11.36% | 0.02% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 340,953 | $4.51 M | 150.62% | 0.02% |
| QRG CAPITAL MANAGEMENT, INC. | 02/05/2025 | 329,644 | $4.36 M | 16.83% | 0.02% |
| ETHIC INC. | 02/14/2025 | 326,307 | $4.32 M | -25.81% | 0.02% |
| BLEAKLEY FINANCIAL GROUP, LLC | 01/27/2025 | 318,340 | $4.21 M | -5.02% | 0.02% |
| PATHSTONE HOLDINGS, LLC | 02/14/2025 | 316,312 | $4.19 M | -26.55% | 0.02% |
| MANNING & NAPIER ADVISORS LLC | 01/23/2025 | 304,417 | $4.03 M | -4.25% | 0.02% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 301,087 | $3.99 M | 6.02% | 0.02% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 275,000 | $3.64 M | 10.00% | 0.02% |
| JANE STREET GROUP, LLC | 02/14/2025 | 254,647 | $3.37 M | 109.02% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 253,551 | $3.36 M | 35.47% | 0.02% |
| CREATIVE PLANNING | 02/14/2025 | 251,342 | $3.33 M | 59.45% | 0.02% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 233,950 | $3.10 M | -8.77% | 0.01% |
| LMR PARTNERS LLP | 02/14/2025 | 230,000 | $3.05 M | 100.00% | 0.01% |
| SEI INVESTMENTS CO | 02/11/2025 | 222,887 | $2.95 M | -29.46% | 0.01% |
| HANTZ FINANCIAL SERVICES, INC. | 01/23/2025 | 219,171 | $2.90 M | -3.31% | 0.01% |
| CROSSMARK GLOBAL HOLDINGS, INC. | 01/16/2025 | 210,484 | $2.79 M | 284.87% | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 193,203 | $2.56 M | 100.00% | 0.01% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 181,929 | $2.41 M | 59.97% | 0.01% |
| AQUATIC CAPITAL MANAGEMENT LLC | 02/14/2025 | 180,927 | $2.40 M | 52.04% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 179,938 | $2.38 M | 38.29% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Takeda Pharmaceutical Company Limited institutional Ownership - FAQ's
During the previous two years, 416 institutional investors and hedge funds held shares of Takeda Pharmaceutical Company Limited. The most heavily invested institutionals were:
Capital Research Global Investors: 13.16 M
MORGAN STANLEY: 5.6 M
GOLDMAN SACHS GROUP INC: 4.63 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 4.22 M
FMR LLC: 3.39 M
FIRST TRUST ADVISORS LP: 3.24 M
4.55% of Takeda Pharmaceutical Company Limited stock is owned by institutional investors.
Institutional investors have bought a total of 90.81 M shares in the last 24 months. This purchase volume represents approximately $1.36 B in transactions.